A Study to Evaluate the Persistence and Immune Response to a Booster Dose of MenACWY

NCT01018732 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

155

Enrollment

INDUSTRY

Sponsor class

Conditions

Meningococcal Disease
Meningococcal Meningitis

Interventions

BIOLOGICAL: Novartis Meningococcal (MenACWY-CRM) vaccine

Sponsor

Novartis Vaccines

Collaborators

[object Object]